Abreos Biosciences
San Diego
About Abreos Biosciences
Abreos Biosciences develops lateral flow assays that measure the activity of high-value biologics. Its simple devices can be used for quality assurance, pharmacokinetic monitoring, and authentication in field, forensic, or point of care settings. We deliver value by enhancing brand protection, improving patients’ outcomes, and enabling rapid authentication for counterfeit prevention and end-user confidence. The company was founded in 2013 and headquartered in San Diego, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $8.6M
- Funding stage: Private Equity
- Last round: Private Equity (Sep 2020)
- Website: abreos.com
- Phone: 8588226333
Industries & Categories
Biotechnology, Clinical Trials, Medical
Social Profiles
Canonical: https://fsome.com/organization/abreos-biosciences-24529 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.